- Home
- EXEL vs ENTG Comparison
EXEL vs ENTG Comparison
Compare EXEL & ENTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- ENTG
- Stock Information
- Founded
- EXEL 1994
- ENTG 1966
- Country
- EXEL United States
- ENTG United States
- Employees
- EXEL 1147
- ENTG N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- ENTG Plastic Products
- Sector
- EXEL Health Care
- ENTG Industrials
- Exchange
- EXEL Nasdaq
- ENTG Nasdaq
- Market Cap
- EXEL 11.3B
- ENTG 11.9B
- IPO Year
- EXEL 2000
- ENTG 2000
- Fundamental
- Price
- EXEL $40.37
- ENTG $75.42
- Analyst Decision
- EXEL Buy
- ENTG Strong Buy
- Analyst Count
- EXEL 18
- ENTG 9
- Target Price
- EXEL $39.59
- ENTG $113.22
- AVG Volume (30 Days)
- EXEL 2.6M
- ENTG 3.6M
- Earning Date
- EXEL 08-05-2025
- ENTG 07-30-2025
- Dividend Yield
- EXEL N/A
- ENTG 0.53%
- EPS Growth
- EXEL 237.58
- ENTG N/A
- EPS
- EXEL 2.20
- ENTG 2.04
- Revenue
- EXEL $2,298,922,000.00
- ENTG $3,243,408,000.00
- Revenue This Year
- EXEL $9.37
- ENTG $1.57
- Revenue Next Year
- EXEL $11.05
- ENTG $8.81
- P/E Ratio
- EXEL $18.12
- ENTG $36.93
- Revenue Growth
- EXEL 24.49
- ENTG N/A
- 52 Week Low
- EXEL $21.36
- ENTG $60.75
- 52 Week High
- EXEL $48.85
- ENTG $147.57
- Technical
- Relative Strength Index (RSI)
- EXEL 42.39
- ENTG 48.62
- Support Level
- EXEL $41.03
- ENTG $75.05
- Resistance Level
- EXEL $42.07
- ENTG $79.58
- Average True Range (ATR)
- EXEL 0.95
- ENTG 3.07
- MACD
- EXEL -0.42
- ENTG 0.38
- Stochastic Oscillator
- EXEL 12.85
- ENTG 61.32
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About ENTG Entegris Inc.
Entegris Inc is a supplier of materials and process solutions for the semiconductor and other high-technology industries. The company's reportable segments include The Materials Solutions segment which provides materials-based solutions, such as chemical vapor and atomic layer deposition materials, chemical mechanical planarization slurries and pads, ion implantation specialty gases, formulated etch and clean materials, and other specialty materials. The Advanced Purity Solutions segment offers filtration, purification and contamination-control solutions that improve customers' yield, device reliability and cost by ensuring the purity of critical liquid chemistries and gases and the cleanliness of wafers and other substrates.